JP2024517769A - Lpaアンタゴニストとしての新規トリアゾール-ピリジン置換ピロリジニル及びテトラヒドロ-2h-ピラニル酢酸化合物 - Google Patents

Lpaアンタゴニストとしての新規トリアゾール-ピリジン置換ピロリジニル及びテトラヒドロ-2h-ピラニル酢酸化合物 Download PDF

Info

Publication number
JP2024517769A
JP2024517769A JP2023566850A JP2023566850A JP2024517769A JP 2024517769 A JP2024517769 A JP 2024517769A JP 2023566850 A JP2023566850 A JP 2023566850A JP 2023566850 A JP2023566850 A JP 2023566850A JP 2024517769 A JP2024517769 A JP 2024517769A
Authority
JP
Japan
Prior art keywords
alkyl
ring
cycloalkyl
methyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023566850A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024517769A5 (cg-RX-API-DMAC7.html
Inventor
ホンジャン ジャン
ピン チェン
ジェンウェイ ツァイ
フェイ ジャン
ペイファ スン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2024517769A publication Critical patent/JP2024517769A/ja
Publication of JP2024517769A5 publication Critical patent/JP2024517769A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2023566850A 2021-04-30 2022-04-28 Lpaアンタゴニストとしての新規トリアゾール-ピリジン置換ピロリジニル及びテトラヒドロ-2h-ピラニル酢酸化合物 Pending JP2024517769A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2021091510 2021-04-30
CNPCT/CN2021/091510 2021-04-30
PCT/US2022/026832 WO2022232459A1 (en) 2021-04-30 2022-04-28 Novel triazole-pyridine substituted pyrrolidinyl and tetrahydro-2h-pyranyl acetic acid compounds as lpa antagonists

Publications (2)

Publication Number Publication Date
JP2024517769A true JP2024517769A (ja) 2024-04-23
JP2024517769A5 JP2024517769A5 (cg-RX-API-DMAC7.html) 2025-05-01

Family

ID=81748636

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023566850A Pending JP2024517769A (ja) 2021-04-30 2022-04-28 Lpaアンタゴニストとしての新規トリアゾール-ピリジン置換ピロリジニル及びテトラヒドロ-2h-ピラニル酢酸化合物

Country Status (10)

Country Link
US (1) US20250230140A1 (cg-RX-API-DMAC7.html)
EP (1) EP4330249A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024517769A (cg-RX-API-DMAC7.html)
KR (1) KR20240044386A (cg-RX-API-DMAC7.html)
CN (1) CN117751106A (cg-RX-API-DMAC7.html)
AU (1) AU2022264579A1 (cg-RX-API-DMAC7.html)
CA (1) CA3218258A1 (cg-RX-API-DMAC7.html)
IL (1) IL308035A (cg-RX-API-DMAC7.html)
MX (1) MX2023012830A (cg-RX-API-DMAC7.html)
WO (1) WO2022232459A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023109878A1 (zh) * 2021-12-15 2023-06-22 武汉人福创新药物研发中心有限公司 三氮唑类lpar1拮抗剂及其用途
CN121773091A (zh) * 2023-09-08 2026-03-31 西藏海思科制药有限公司 杂芳环衍生物的lpar1拮抗剂及其用途
IL326963A (en) * 2023-09-08 2026-05-01 Haisco Pharmaceutical Group Co Ltd LPAR1 antagonist and its use
WO2026119206A1 (zh) * 2024-12-05 2026-06-11 海思科医药集团股份有限公司 Lpar1拮抗剂药物组合物及其在医药上的应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020147739A1 (zh) * 2019-01-15 2020-07-23 武汉朗来科技发展有限公司 溶血磷脂酸受体拮抗剂及其制备方法
JP2021506860A (ja) * 2017-12-19 2021-02-22 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company Lpaアンタゴニストとしてのシクロヘキシル酸トリアゾールアジン
JP2021507899A (ja) * 2017-12-19 2021-02-25 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company Lpaアンタゴニストとしてのイソキサゾールo−架橋カルバモイルシクロヘキシル酸

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2946657T3 (es) * 2018-09-18 2023-07-24 Bristol Myers Squibb Co Acidos ciclopentílicos como antagonistas de LPA
KR20220024548A (ko) * 2019-06-18 2022-03-03 브리스톨-마이어스 스큅 컴퍼니 Lpa 길항제로서의 트리아졸 카르복실산
IL300525A (en) * 2020-08-11 2023-04-01 Viva Star Biosciences Ltd Triazole-pyridinyl-substituted azacyclohexyl acetic acid compounds as LPA receptor antagonists

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021506860A (ja) * 2017-12-19 2021-02-22 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company Lpaアンタゴニストとしてのシクロヘキシル酸トリアゾールアジン
JP2021507899A (ja) * 2017-12-19 2021-02-25 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company Lpaアンタゴニストとしてのイソキサゾールo−架橋カルバモイルシクロヘキシル酸
WO2020147739A1 (zh) * 2019-01-15 2020-07-23 武汉朗来科技发展有限公司 溶血磷脂酸受体拮抗剂及其制备方法

Also Published As

Publication number Publication date
IL308035A (en) 2023-12-01
MX2023012830A (es) 2024-01-19
WO2022232459A1 (en) 2022-11-03
US20250230140A1 (en) 2025-07-17
EP4330249A1 (en) 2024-03-06
CN117751106A (zh) 2024-03-22
AU2022264579A1 (en) 2023-12-14
CA3218258A1 (en) 2022-11-03
KR20240044386A (ko) 2024-04-04

Similar Documents

Publication Publication Date Title
CN116669727B (zh) 作为lpa受体拮抗剂的三唑-吡啶基取代的氮杂环己基乙酸化合物
US20240109891A1 (en) Novel substituted tricyclic aza-heterocycles as sos1 inhibitors
AU2015284135B2 (en) Heteroaryl compounds useful as inhibitors of SUMO activating enzyme
ES2936517T3 (es) Triazol azinas de ácido ciclohexílico como antagonistas de LPA
EP4330249A1 (en) Novel triazole-pyridine substituted pyrrolidinyl and tetrahydro-2h-pyranyl acetic acid compounds as lpa antagonists
US20240109887A1 (en) Novel substituted bicyclic aza-heterocycles as sos1 inhibitors
AU2014234908A1 (en) N-(2-cyano heterocyclyl)pyrazolo pyridones as Janus kinase inhibitors
WO2019169539A1 (en) Novel oxa-and aza-tricyclic 4-pyridone-3-carboxylic acid for treatment and prophylaxis of hepatitis b virus infection
JP2024538602A (ja) インターロイキン-1活性の阻害剤としての新規の置換スルホニル尿素化合物
JP2021505568A (ja) ドーパミン−β−ヒドロキシラーゼ阻害剤
JP7389905B2 (ja) ブルトン型チロシンキナーゼ阻害剤としてのイミダゾールカルボキサミド誘導体
KR20240165360A (ko) 에모파밀 결합 단백질 억제제 및 이의 용도
US12338255B2 (en) Bicyclic substituted sulfonylurea compounds as inhibitors of interleukin-1 activity
HK40102702A (en) Novel triazole-pyridine substituted pyrrolidinyl and tetrahydro-2h-pyranyl acetic acid compounds as lpa antagonists
HK40116219A (en) Novel bicyclic substituted sulfonylurea compounds as inhibitors of interleukin-1 activity
HK40100136A (zh) 作为lpa受体拮抗剂的三唑-吡啶基取代的氮杂环己基乙酸化合物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231226

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250422

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250422

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260122

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20260122

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260410

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260624

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20260629

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20260731